Stay updated with breaking news from Avery Ince. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ince describes why patients who are considered fragile are often underdiagnosed and undertreated, and that the VOYAGER PAD analyses can encourage the treatment of the fragile population.
TITUSVILLE, NJ,March 5, 2023 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from a new prespecified analysis from the Phase 3 VOYAGER PAD clinical trial... | March 5, 2023
This week, our guests are Viktoriya Vasilenko, from Knowledge Gate, and Avery Ince, from Janssen Scientific Affairs.
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing that...
TITUSVILLE, NJ, December 9, 2022 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing that... | December 9, 2022